Caspian Journal of Internal Medicine
Babol University of Medical Sciences
پنجشنبه 13 دی 1403
[Archive]
دوره 14، شماره 4 - ( 6-1402 )
جلد 14 شماره 4 صفحات 745-741 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eslami B, Omranipour R, Aryan A, Bayani L, Abedi M, Alipour S. Association of metformin and aspirin intake with mammographic breast density: a cross-sectional study. Caspian J Intern Med 2023; 14 (4) :741-745
URL: http://caspjim.com/article-1-3636-fa.html
URL: http://caspjim.com/article-1-3636-fa.html
Association of metformin and aspirin intake with mammographic breast density: a cross-sectional study. . 1402; 14 (4) :741-745
چکیده: (1009 مشاهده)
Background: Our purpose was to investigate the association between Mammographic breast density (MBD), a known strong marker for breast cancer and metformin and aspirin use and duration of use alone or simultaneously, in a sample of Iranian women considering other confounding factors.
Methods: In a cross-sectional study, 712 individuals were selected out of women referred to two university hospitals for screening mammography. Participants’ information was collected with a questionnaire. Four-category density scale (a = almost entirely fatty, b = scattered fibroglandular densities, c= heterogeneously dense, and d = extremely dense) was categorized as low (a&b) and high (c&d) density.
Results: The mean age of the participants was 49.80 ± 7.26 years. Sixty-five percent of women belonged to the high and 35% to the low MBD category. Both aspirin and metformin had a significantly negative association with MBD, however, when confounding factors were entered into the models, only aspirin after adjustment for age and BMI had an inverse association with MBD (OR = 0.53, 95% CI: 0.35-0.94). Simultaneous use of metformin and aspirin (OR = 0.44, 95 %CI: 0.17-1.12) was associated with lower MBD. Furthermore, in women who used metformin (OR = 0.23, 95% CI: 0.09-0.62) and aspirin (O R= 0.35, 95% CI: 0.17-0.72) for 2 to 5 years, MBD was significantly lower. However, after the adjustment of confounding factors, these associations were not statistically significant.
Conclusion: It seems metformin and aspirin intakes are associated with MBD. However, further studies with more sample size are needed.
Methods: In a cross-sectional study, 712 individuals were selected out of women referred to two university hospitals for screening mammography. Participants’ information was collected with a questionnaire. Four-category density scale (a = almost entirely fatty, b = scattered fibroglandular densities, c= heterogeneously dense, and d = extremely dense) was categorized as low (a&b) and high (c&d) density.
Results: The mean age of the participants was 49.80 ± 7.26 years. Sixty-five percent of women belonged to the high and 35% to the low MBD category. Both aspirin and metformin had a significantly negative association with MBD, however, when confounding factors were entered into the models, only aspirin after adjustment for age and BMI had an inverse association with MBD (OR = 0.53, 95% CI: 0.35-0.94). Simultaneous use of metformin and aspirin (OR = 0.44, 95 %CI: 0.17-1.12) was associated with lower MBD. Furthermore, in women who used metformin (OR = 0.23, 95% CI: 0.09-0.62) and aspirin (O R= 0.35, 95% CI: 0.17-0.72) for 2 to 5 years, MBD was significantly lower. However, after the adjustment of confounding factors, these associations were not statistically significant.
Conclusion: It seems metformin and aspirin intakes are associated with MBD. However, further studies with more sample size are needed.
نوع مطالعه: Original Article |
موضوع مقاله:
Oncology
دریافت: 1401/6/5 | پذیرش: 1401/8/14 | انتشار: 1402/6/24
دریافت: 1401/6/5 | پذیرش: 1401/8/14 | انتشار: 1402/6/24
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
